Future coverage trends : Among large employers that do not currently cover GLP-1 drugs for weight loss, 62% say they are not likely to add coverage within the next year
For example, those who follow vegan or vegetarian diets or are over the age of 60 may need supplementation (Pawlak, 2014
(2025, Nature Metabolism ) reported daLUXendin and daLUXendin+, non-lipidated and lipidated dual GLP-1/GIP receptor agonist fluorescent probes with nanomolar affinity at both hGLP1R and hGIPR
It comes in single-use ampoules, typically 5 mL or 10 mL, and is intended to be drawn up entirely in one preparation and the remainder discarded
It also helps keep nails, skin, and hair healthy
Weeks 13-16: The Optimization Phase (1.7 mg) For those who tolerate the medication well and need additional weight loss support, the dose may increase to 1.7 mg weekly